Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Clinical importance of laboratory biomarkers in liver fibrosis
Valdas Banys, Goda Aleknavičiūtė-Valienė
Biochemia Medica (2022) Vol. 32, Iss. 3, pp. 346-356
Open Access | Times Cited: 20

Showing 20 citing articles:

Metabolic dysfunction-associated fatty liver disease: current therapeutic strategies
Khamis Al-Hashmi, Rosaria Vincenza Giglio, Anca Pantea Stoian, et al.
Frontiers in Nutrition (2024) Vol. 11
Open Access | Times Cited: 10
Obeticholic acid-loaded exosomes attenuate liver fibrosis through dual targeting of the FXR signaling pathway and ECM remodeling
Arezou Azizsoltani, Behzad Hatami, Mohammad Reza Zali, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 168, pp. 115777-115777
Open Access | Times Cited: 18
Performance Evaluation of a Novel Non-Invasive Test for the Detection of Advanced Liver Fibrosis in Metabolic Dysfunction-Associated Fatty Liver Disease
Anna Stefańska, Katarzyna Bergmann, Szymon Suwała, et al.
Metabolites (2024) Vol. 14, Iss. 1, pp. 52-52
Open Access | Times Cited: 4
New Biomarkers in Liver Fibrosis: A Pass through the Quicksand?
Marzia Tagliaferro, Mariapaola Marino, Valerio Basile, et al.
Journal of Personalized Medicine (2024) Vol. 14, Iss. 8, pp. 798-798
Open Access | Times Cited: 4
Single and multi-omic characterization of a porcine model of ethanol-induced hepatic fibrosis
Mark Hieromnimon, Daniel P. Regan, R. Peter Lokken, et al.
Epigenetics (2025) Vol. 20, Iss. 1
Open Access
Assessment of liver involvement in Wilson’s disease with different liver echo patterns based on liver stiffness evaluated on Transient elastography and Sound Touch Viscoelastography
Yan Li, Baoqi Li, Jin Fu, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Correlation Analysis of IL-17, IL-21, IL-23 with Non-Alcoholic Liver Fibrosis and Cirrhosis
Xiaoyan Yang, Liyin Liao, Zizhen Liang, et al.
Journal of Inflammation Research (2024) Vol. Volume 17, pp. 2327-2335
Open Access | Times Cited: 3
Serum α-SMA is a potential noninvasive biomarker of liver fibrosis
Irina Cardoso-Lezama, Erika Ramos‐Tovar, Jaime Arellanes‐Robledo, et al.
Toxicology Mechanisms and Methods (2023) Vol. 34, Iss. 1, pp. 13-19
Closed Access | Times Cited: 8
Research Progress of Fibroblasts in Human Diseases
Xiaodong Li, Nana Li, Yujie Wang, et al.
Biomolecules (2024) Vol. 14, Iss. 11, pp. 1478-1478
Open Access | Times Cited: 2
Non-invasive Serological Markers of Hepatic Fibrosis – Mini Review
Popa Elena, Avram Raluca Ioana, Popa Andrei Emilian, et al.
Archives of Surgery and Clinical Research (2024) Vol. 8, Iss. 1, pp. 032-038
Open Access | Times Cited: 1
A candidate reference measurement procedure for quantification of glycocholic acid in human serum based on isotope dilution liquid chromatography-tandem mass spectrometry
P Zhang, Huimin Wang, Liang Man, et al.
Analytical and Bioanalytical Chemistry (2024) Vol. 416, Iss. 23, pp. 5121-5131
Open Access
Effects of Bushen Huayu Decoction combined with entecavir on liver function and hepatic fibrosis in patients with compensated cirrhosis
Wei Yu, GE Chang-qing
American Journal of Translational Research (2024) Vol. 16, Iss. 8, pp. 4163-4173
Closed Access
Assessing the predictive efficacy of noninvasive liver fibrosis indices and portal vein diameter in predicting esophageal variceal bleeding in patients with cirrhosis
Xiaoxiao Lin, Qiaoli Lan, Ya Liu, et al.
Journal of Cardiothoracic Surgery (2024) Vol. 19, Iss. 1
Open Access
Navigating liver health with metabolomics: A comprehensive review
Pushpendra Singh, Ravinder Singh, Chirag Pasricha, et al.
Clinica Chimica Acta (2024) Vol. 566, pp. 120038-120038
Closed Access
Correlation Between Real-Time Shear Wave Elastography and Liver Serum Markers in Determining the Stage of Liver Fibrosis in Patients with Chronic Liver Diseases
Arzana Hasani Jusufi, Мери Трајковска
PRILOZI (2024) Vol. 45, Iss. 3, pp. 85-106
Open Access
Exploratory study of extracellular matrix biomarkers for non-invasive liver fibrosis staging: A machine learning approach with XGBoost and explainable AI
Valeria Carnazzo, Stefano Pignalosa, Marzia Tagliaferro, et al.
Clinical Biochemistry (2024), pp. 110861-110861
Open Access
Pharmacotherapy of Liver Fibrosis and Hepatitis: Recent Advances
Liangtao Zhao, Haolan Tang, Zhangjun Cheng
Pharmaceuticals (2024) Vol. 17, Iss. 12, pp. 1724-1724
Open Access
The Combination of Noninvasive Tests and Fibroscan for the Assessment of Liver Fibrosis among Patients with Nonalcoholic Fatty Liver Disease
Muntadher Abdulkareem Abdullah, Raghad Jawad Al-Akayshee, Kamal Breesam Lafta
AL-Kindy College Medical Journal (2023) Vol. 19, Iss. 3, pp. 12-20
Open Access | Times Cited: 1
Glycosaminoglycans as disease biomarkers: a systematic review
L Lenzi, João Baptista Gomes dos Santos, Aline Mendes, et al.
Revista Eletrônica Acervo Saúde (2023) Vol. 23, Iss. 9, pp. e13095-e13095
Open Access
Editorial: Metabolomics in chronic hepatitis C: Decoding fibrosis grading and underlying pathways
Jorge Quarleri, M. Victoria Delpino
World Journal of Hepatology (2023) Vol. 15, Iss. 11, pp. 1170-1173
Open Access
Page 1

Scroll to top